Intrauterine Contraceptive Devices (IUD) Market by Type, End-user, and Geography - Forecast and Analysis 2023-2027

To learn more about this report, Download Report Sample

COVID-19 Analysis

• This report forecasts the contribution of all the segments to the growth of the market. In addition, we have included the COVID-19 impact and the recovery strategies for each segment. The outbreak of COVID-19 led to a slight decline in the demand for intrauterine contraceptive devices in North America.
• By the second half of 2020, most of the restrictions in various countries had been relaxed to some extent, which allowed business activities and essential services, including the sales of intrauterine devices, to resume. The relaxation of the restrictions following the initiation of large-scale vaccination drives encouraged people to go for health checkups and treatments, which will drive the growth of the intrauterine contraceptive devices (IUD) market in North America during the forecast period.

Parent Market Analysis

Technavio categorizes the global intrauterine contraceptive devices (IUD) market as a part of the global healthcare equipment market. The parent global healthcare equipment market covers products and companies engaged in research and development (R&D) of a variety of product categories, including capital equipment, instruments, implants, accessories, and consumables that are used for the diagnosis, monitoring, and treatment of various diseases. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.

Who are the Major Intrauterine Contraceptive Devices (IUD) Market Vendors?

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Abbvie - The company offers intrauterine contraceptive devices such as the LILETTA (levonorgestrel-releasing) intrauterine contraceptive. 

What is the Fastest-Growing Segment in the Intrauterine Contraceptive Devices (IUD) Market?

The market share growth by the hormonal intrauterine device segment will be significant during the forecast period. Hormonal intrauterine devices contain the hormone progestin, which inhibits ovulation by thinning the uterus lining and thickening the cervical mucus that blocks the sperm from reaching the egg, thereby preventing fertilization.

Get a glance at the market contribution of various segments Request a PDF Sample

The Hormonal intrauterine device segment showed a gradual increase in the market share of USD 3037.39 million in 2017 and continue to grow by 2021. Hormonal intrauterine devices decrease the risk of pelvic inflammatory disease (PID) and tubal pregnancies and help in treating symptoms such as polycystic ovary syndrome (PCOS) and endometriosis. Hormonal intrauterine devices are more effective in preventing pregnancies when compared with other contraception devices. They are superior to copper intrauterine devices and pose fewer complications and risks. Furthermore, our report provides a brief analysis of the historical and forecast market share and their segments along with the reasons for growth from 2017 to 2027.

Which are the Key Regions for the Intrauterine Contraceptive Devices (IUD) Market?

For more insights on the market share of various regions Request PDF Sample now!

North America is projected to contribute 33% of market growth by 2027. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. 

The US leads the intrauterine contraceptive devices (IUD) market in North America. The presence of local market players, supportive government initiatives, high awareness, and technological innovations such as postpartum and reusable IUDs drive market growth in the US.

Intrauterine Contraceptive Devices (IUD) Market: Key Drivers, Trends, Challenges, and Customer Landscape

The increasing number of unplanned pregnancies and unwanted abortions is notably driving the IUD market growth, although factors such as the adverse effects of IUDs may impede the market growth. Our researchers analyzed the data with 2022 as the base year and the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Intrauterine Contraceptive Devices (IUD) Market Driver

• The increasing number of unplanned pregnancies and unwanted abortions is the key factor driving the global intrauterine contraceptive devices (IUD) market growth. The growing number of unplanned pregnancies is expected to contribute to the growth of the global intrauterine contraceptive devices (IUD) market. 
• Pregnancy despite birth control is not uncommon, as many birth control measures can have a high chance of failure. They also require frequent and specific actions on the part of the user. However, the chances of pregnancy decrease significantly with the use of IUDs if used correctly. IUDs do not require frequent actions on the part of the user, except during the insertion procedure and occasional checkups, and last for almost ten years, thereby providing a hassle-free method of preventing chances of unplanned pregnancies.

Significant Intrauterine Contraceptive Devices (IUD) Market Trend

• The long-term efficacy and increased acceptance of IUDs will fuel the global intrauterine contraceptive devices (IUD) market growth. Unintended pregnancy rates have declined since the 1990s globally. However, the rate is still high and varies widely across regions. In developed regions, unplanned pregnancy rates have declined at a faster rate than in developing regions. The decrease in the number of unplanned pregnancies has reduced the rate of abortions.
• The stigma on birth control has decreased over the years. Today, couples want to control the timing and spacing of the birth of children, both for financial convenience and the mother's health. An IUD helps in spacing births by providing contraception and preventing unwanted pregnancies. Higher awareness of the significance of family planning is leading to the increased adoption of contraceptive methods, leading to better healthcare outcomes for both the mother and the baby.

Major Intrauterine Contraceptive Devices (IUD) Market Challenge

• The adverse effects of IUDs are a major challenge to the global intrauterine contraceptive devices (IUD) market growth. Risks and concerns over the use of Intrauterine devices basically arise from the failure of the Dalkon Shield, which has led to stigma over the use of intrauterine devices and labelled them unsafe.
• In 1970, in the US, A.H. Robins Company acquired the Dalkon Shield from the Dalkon Corporation, founded by Hugh J. Davis, M.D. The contraceptive device was supposed to prevent pregnancy by being directly placed into a woman's uterus. However, in the 1980s, researchers found several serious flaws in the device. The multifilament string attached to the shield enabled bacteria to enter the body through the uterus easily, leading to sepsis (blood poisoning), miscarriages, hysterectomies, pelvic infections, and infertility. Such adverse effects of the use of IUDs can make individuals opt for other contraceptive methods, which will hamper the growth of the market in focus during the forecast period.

Key Intrauterine Contraceptive Devices (IUD) Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Intrauterine Contraceptive Devices (IUD) Market Customer Landscape

 

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by Type (Hormonal intrauterine device and Copper intrauterine device), End-user (Hospitals, Gynecology clinics, and Others), and Geography (North America, Europe, APAC, and Rest of World (ROW)).

• Type Outlook (USD Million, 2017 - 2027)
  • Hormonal intrauterine device
  • Copper intrauterine device

• End-user Outlook (USD Million, 2017 - 2027)
  • Hospitals
  • Gynecology clinics
  • Others

• Region Outlook (USD Million, 2017 - 2027)
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • APAC
    • China
    • India
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa

Intrauterine Contraceptive Devices (IUD) Market Scope
Report Coverage	Details
Page number	149
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 3.98%
Market growth 2023-2027	USD 965.49 million
Market structure	Fragmented
YoY growth 2022-2023(%)	3.68
Regional analysis	North America, Europe, APAC, and Rest of World (ROW)
Performing market contribution	North America at 33%
Key countries	US, China, Japan, Germany, and France
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd, Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., and Viatris Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Intrauterine Contraceptive Devices (IUD) Market Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the intrauterine contraceptive devices (IUD) market between 2023 and 2027
• Precise estimation of the size of the intrauterine contraceptive devices (IUD) market size and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming trends and changes in consumer behaviour
• Growth of the market industry across North America, Europe, APAC, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of intrauterine contraceptive devices (IUD) market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch